Lacosamide Neuraxpharm

Lacosamide, the active ingredient in Lacosamide Neuraxpharm, is an anticonvulsant presented as an oral tablet for oral use. It treats partial‑onset seizures in patients with epilepsy as an adjunct therapy.

GNH USA supplies Lacosamide Neuraxpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide Neuraxpharm is an anticonvulsant that acts on neuronal sodium channels to control seizure activity.

Partial‑onset seizures (focal epilepsy): Reduces seizure frequency when added to existing antiepileptic regimens. Adjunctive treatment of epilepsy: Enhances overall seizure control in combination with other approved therapies.

Lacosamide may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Dizziness - Headache - Nausea - Fatigue - Blurred vision - Diplopia

Serious or Rare Side Effects: - Cardiac conduction abnormalities (e.g., PR‑interval prolongation) - Severe skin reactions such as Stevens‑Johnson syndrome - Suicidal thoughts or behavior - Hepatic injury - Respiratory depression - Blood dyscrasias

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.

Renal impairment: Adjust dose or monitor renal function as needed. Hepatic impairment: Monitor liver enzymes and consider dose modification. Cardiac conduction disorders: Use with caution; baseline ECG may be required. Pregnancy: Potential risk unknown; prescribe only if benefit outweighs risk. Concomitant CNS depressants: Observe for additive sedation or respiratory effects. Store at ambient temperature: Keep below 25 °C in original packaging, protect from moisture and direct sunlight.

Lacosamide can interact with several medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., carbamazepine): May reduce lacosamide plasma levels. - Other sodium‑channel blockers (e.g., phenytoin): Increased risk of CNS depression. - Drugs that prolong PR interval (e.g., verapamil): Potential for cardiac conduction issues.

Moderate Interactions (Monitor Closely): - Oral contraceptives: May decrease contraceptive effectiveness. - Alcohol: Can enhance dizziness and sedation.